Royalty Pharma plc
RPRX
Rank in Stocks
#892
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Share Price
$60.39
Last synced: 2026-10-19
Market Cap
$26.89B
Change (1 day)
-0.93%
Change (1 year)
64.87%
Country
US
Trade Royalty Pharma plc (RPRX)
Category
Healthcare
Stock split history for Royalty Pharma plc (RPRX)
Royalty Pharma plc stock (symbol: RPRX) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One RPRX share bought prior to Oct 20, 2026 would equal to 0 RPRX shares today.
The most recent stock split occurred on Oct 20, 2026.
One RPRX share bought prior to Oct 20, 2026 would equal to 0 RPRX shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
IT
|
|
| 7 | x40 |
HK
|
|
| 0 | - |
US
|
